Table 4.
Parameter | Reference # | Barbados | Ghana |
---|---|---|---|
Population Demographics | |||
Population | 35 | 279,912 | 22,409,572 |
Population age and gender pyramid | 36 | ||
Mortality | 34 | ||
| |||
Medical Costs | |||
New patient, adult medical eye exam | U.S. CPT 92002, 23 | $39.58 | $37.06 |
New patient, comprehensive adult medical eye exam | U.S. CPT 92004, 23 | $69.78 | $65.00 |
Established patient, comprehensive adult medical eye exam | U.S. CPT 92012, 23 | $41.18 | $39.26 |
Eye exam and treatment | U.S. CPT 92014, 23 | $56.96 | $53.81 |
Gonioscopy | U.S. CPT 92020, 23 | $14.07 | $13.01 |
Automatic threshold perimetry | U.S. CPT 92083, 23 | $55.79 | $54.36 |
Annual cost of beta blockers | 25 | $8.36 | $5.35 |
Annual cost of prostaglandin analogues | 25 | $126.48 | $56.32 |
Annual cost of alpha-2 agonists | Calculated from U.S. AWP | $147.01 | $110.05 |
Annual cost of topical carbonic inhibitors | 25 | $156.19 | $156.19 |
Trabeculectomy | U.S. CPT 3x92014, 3x92020, 23 | $503.56 | $468.79 |
Trabecluoplasty | U.S. CPT 92014, 92083, 92285, 23 | $176.03 | $165.03 |
| |||
Utility and Disability Parameters | |||
DALY, WHO blindness | 3 | 0.60 | 0.60 |
DALY, WHO visual impairment | 3 | 0.244 | 0.282 |
Productivity Parameters | |||
GDP real growth rate | 29 | 2.10% | 1.90% |
GDP per capita | 29 | $15,560 | $2,240 |
Gini coefficient | 30 | 0.39 | – |
Share of GDP of wealthiest 10% | 29 | – | 0.30 |
AWP = average wholesale price, CPT = Current Procedural Terminology, DALY = disability-adjusted life year, GDP = gross domestic product, WHO = World Health Organization